Status:
COMPLETED
Montelukast and Loratadine in Children With Asthma
Lead Sponsor:
Innovacion y Desarrollo de Estrategias en Salud
Collaborating Sponsors:
National Institute of Pediatrics, Mexico
Laboratorios Senosiain, S.A. de C.V.
Conditions:
Asthma in Children
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
Randomized controlled trial in 80 children with mild to persistent moderate asthma, who were randomized to receive montelukast 5mg + loratadine 5mg vs. montelukast 5mg + placebo for loratadine to eval...
Detailed Description
Asthma is a disease with increasing prevalence worldwide that produces significant deterioration of the quality of life in children and development of important complications and economic, social impa...
Eligibility Criteria
Inclusion
- Age from 6 to 12 years old
- Any sex
- Persistent mild to moderate asthma
- Signature of informed consent letter by parents or guardians
- Letter of assent of the minor for children over 9 years of age
Exclusion
- Chronic pathologies associated with the disease of interest (heart disease, nephropathy, liver disease of any kind)
- Any other lung disease other than asthma
- History of hypersensitivity to montelukast or loratadine
- Concomitant use of medications that interact significantly with montelukast or loratadine
Key Trial Info
Start Date :
January 10 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03372473
Start Date
January 10 2016
End Date
June 30 2017
Last Update
December 13 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.